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ABSTRACT The visible wavelength excited fluorophore 3,3'-dioctadecylindocarbocyanine io-
dide (dil[3]) was incorporated into human low density lipoprotein (LDL) to form the highly
fluorescent LDL derivative dil(3)-LDL . Dil(3)-LDL binds to normal human fibroblasts and to
human fibroblasts defective in LDL receptor internalization but does not bind to LDL receptor-
negative human fibroblasts at 4°C or 37°C. It is internalized rapidly at 37°C by normal
fibroblasts and depresses the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase
(HMG-CoA reductase) in a manner similar to that of LDL. It is prevented from binding to the
LDL receptor by an excess of unlabeled LDL or by heparin sulfate. Identical distributions of
dil(3)-LDL are observed on cells by either indirect immunofluorescence with fluorescein-
labeled antibody or directly by dil(3) fluorescence. Upwards of 45 molecules of dil(3) are
incorporated per molecule of LDL without affecting binding to the receptor. This labeling
renders individual molecules visible by their fluorescence and enables the derivative to be
used in dynamic studies of LDL-receptor motion on living fibroblasts by standard fluorescence
techniques at low LDL receptor density. Observations with this derivative indicate that the
LDL-receptor complex is immobilized on the surface of human fibroblasts but, when free of
this linkage, undergoes a Brownian motion consistent with theory.
The means by which cells communicate information about
ligand binding is the subject of intense investigation (1-5).
Some of the insight gained in this area derives from study of
the receptor system for low density lipoprotein (LDL) (6, 7).
The LDL molecule is the predominant carrier of plasma cho-
lesterol (6, 8, 9). Due to cholesterol's importance in the study
of atherosclerosis and heart disease (6, 10), the genetics of
certain diseases of cholesterol regulation are well known. In
particular, diseases of cholesterol metabolism and synthesis
have been associated with the LDL receptor (11-14). One
human cell type, GM-2408A or J.D., has been shown to have
a functional LDL receptor that binds LDL but is unable to
effect its internalization (13, 15, 16). Another human cell line,
GM-2000, lacks LDL receptors. In both conditions, the patients
manifest elevated serum cholesterol levels and their cells are
unable to regulate properly the enzymes involved in cholesterol
synthesis (1, 6).
The LDL-receptor system shares various features common
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to other hormone receptor systems (1, 2, 4, 5). LDL bound at
37°C is rapidly internalized by the cell in specific membrane
areas called coated pits (17-19). Normal human fibroblasts
contain preaggregated LDL receptor in coated pits (17, 18).
Whether a receptor not located in a coated region can partici-
pate in signal transduction may depend on its ability to move
from a noncoated to a coated area. This condition may apply
to receptor systems other than the one for LDL (3).
Interested in the relationship of receptor motion to signal
transduction, we chose to study this relationship in the LDL
receptor system for the following reasons. Many aspects of the
LDL system subsequent to receptor-ligand internalization have
been characterized (1, 6). Cell mutants exist which are unable
to properly regulate cholesterol synthesis due to defects in the
LDL-receptor system, and the genetics of these defects has
been studied (1, 6, 11-14). The LDL receptor system contains
features characteristic ofother hormone systems (1, 2, 4). Most
important of all, the LDL molecule, because of its size and
595structure, lends itself to multiple labeling by fluorophore while
retaining its biological activity (20, 21). This last point will be
discussed in detail below.
In its natural state, LDL is a large, spherical molecular
complex (Mr = 3 x 106, diameter = 240 A) consisting of
protein, phospholipid, triglyceride, cholesterol, and cholesterol
ester (9, 22). Its exact structure is unknown, though differing
models place phospholipids and its major protein component,
apo B, at the surface of the sphere, with the cholesterol esters
filling the interior (23, 24). A typical LDL may contain 750
phospholipid and 1,300 cholesterol ester molecules (24). The
particular molecules that form the complex allow modification
of LDL in several ways. Kreiger et al. (21) showed that the
esters could be replaced with exogenous UV-excited fluoro-
phores. The distribution of this fluorescent LDL derivative has
been studied on normal fibroblasts (25). This derivative binds
in a pattern similar to that of unsubstituted LDL. LDL in
which the cholesterol esterhas been removed but not replaced
(26) also binds normally to cells but does not suppress the
activity of the microsomalenzyme 3-hydroxy-3-methylglutaryl
coenzyme-A reducatase (HMG-CoA reductase). This enzyme
regulates synthesis of endogenous cell cholesterol (27, 28).
Lipid-soluble probes such as perylene can be incorporated into
the lipid shell of LDL (29) by simple incubation. In the case of
perylene there is probeexchange with the surrounding medium
(29).
We report the incorporation of the lipid analog 3,3' diocta-
decylindolcarbocyanine (dil[31) into human LDL to form the
intensely fluorescent, visible wavelength-excited derivative
diI(3)-LDL. The activity and binding specificity of dil(3)-LDL
are demonstrated in the following ways. We show that dil(3)-
LDL retains antigenic properties of LDL. Cells prepared for
indirect immunofluorescence with antibody against LDL and
labeled with dil(3)-LDL have coincident antibody and diI(3)-
LDL fluorescence distributions. HMG-CoA reductase is in-
hibited by diI(3)-LDL, indicating that the LDL must retain its
cholesterol ester. Furthermore, we present electron microscopic
and spectroscopic results and theoretical arguments which
indicate that the diI(3) probably resides in the LDL-phospho-
lipid shell. In addition, the diI(3)-LDL fluorescence distribu-
tion on normal (GM-3348), LDL receptor-negative (GM-
2000), and LDL receptor internalization-defective human fi-
broblasts (GM-2408A) are examined and compared to each
other and to previous immunofluorescence results (17, 25). By
using these three cell lines as references, we demonstrate that
diI(3)-LDL can be prevented from binding to its receptor by
an excess of unlabeled LDL and displaced from its receptor by
heparin sulfate (30).
MATERIALS AND METHODS
LDL Purification
LDL was purified by density gradient centrifugation (9, 20, 30, 31). Fresh
plasma (<48 h old) was obtained from the RedCross in Syracuse, N. Y.
Reconstitution of LDL with dil(3)
Threeprocedurestoincorporate thelipidanalog dil(3) into LDLaredescribed.
The first, method 1, is essentially that of Kreiger et al. (20, 2l). The second,
method 11, is the procedure of choice. With this procedure the LDLretains the
cholesterol esters. The third procedure, method III, was used to test whether
diI(3) could partition into the LDL-phospholipid shell from an aqueous environ-
ment.
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Method 1
LDL was prepared for reconstitution by the procedure of Kreiger et al. (20,
21). 2 mg of LDL in solution were combined with 25 mg of insoluble potato
starch (Sigma Chemical Co., St. Louis, Mo.) in a Siliclad-treated 13- x 100-mm
test tube (Clay Adams, Div. of Becton, Dickinson & Co., Parsippany, N. J.). The
tubes were vortexed, rapidly frozen in liquid nitrogen, and lyophilized in a
vacuum of1-5 tun .The lyophilized material was stored in a desiccator over P205
at 4°Cuntil use.
The lyophilized LDL was extracted twice for l and 0.5 h, respectively, by
adding 5 ml of -20°C hepatane to each tube, vortexing every 10 min, and
incubating at -20°C. The tubes were centrifuged after each incubation at 2,000
rpm in a Beckman type 40 rotor (Beckman Instruments, Inc., Spinco Div., Palo
Alto, Calif .) at4°Cfor 10 min, and the supernatewas removed. After the second
centrifugation, the pellet was incubated at -20°C for 1.5-2.5 h with 4.5 mg of
dil(3), dried from a freshly prepared solution of diI(3) in methanol, in 0.4 ml of
-20°C heptane. Themixture was evaporated to dryness over an ice bath with a
stream of dry nitrogen. 1 ml of 10 mM Tricine, 0.01% azide at pH 8.2 was added
and each tubewas incubated for 41 hat 4°Cwith occasionalshaking to resuspend
material. The tubes were then centrifuged 10-15 min at 2,000 rpmat 4°C, and
the supernate was removed. The supernate had the red color of dil(3) and
contained the reconstituted LDL. It was centrifuged twice in clean tubes for 20
mineach at 12,000 rpmin a Beckman type 40 rotor to remove tracesofsuspended
matter. The dil(3)-LDL was stored at 4°C in plastic microfuge tubes until use.
Based on results of a Lowry protein assay (32), the yield of reconstituted LDL
averaged 8-12%.
Method 11-Addition of NaCl
Two mg of lyophilized LDL were combined with 4.5 mg of dil(3) in 0.4-0.6
ml of -20°C heptane, incubated, evaporated to dryness, and extracted as
previously described but with a buffer consisting of 0.12 NNaCl, 10 mM Tricine,
and 0.01% azide, pH 8.2. After centrifugation to remove the starch, the yield of
LDLfrom a single extraction basedon a Lowry assay was40-47% of the starting
protein.
Method 111-Dil(3) Labeling of LDL
from Solution
15ILI ofa 10 mg/ml solution ofdil(3) in methanol was added for 1 hto a 0.5-
ml solution containing 2 mg of LDL and 25 mg of insoluble potato starch. The
mixture was rapidly frozen in liquid nitrogen, lyophilized, and purified as
described above for dil(3)-LDL.
Growth and Treatment of Cells
All procedures involving cells were carried out under sterile conditions in a
laminar flow hood (Baker Co., Sanford, Maine). Three human fibroblastic cell
lines, the mutants GM-2000 and GM-2408A and the normal GM-3348, were
obtained from the Human Genetic Mutant Cell Repository (Camden, N. J.).
Cells used for experiments were grown in stock 75 cm' flasks (Corning Medical,
Coming GlassWorks, Coming, N. Y.) at 37°C in a 5% C02 atmosphere incubator
(model 8241) (National Appliance Co., Portland, Oreg.) in a solution of Ham's
F-12 supplemented with 10% Fetal Calf Serum (FCS). Cells were plated onto
#122 x 31 cm' glass cover slips, 4/100 cm' petri dish, at densities of 105 cell per
dish. To remove LDL from the growth medium to increase the number of
receptors per cell (27), the medium was removed after 24-48 h, the cells were
washed once with Medium 199 (Grand Island Biological Co., Grand Island,
N. Y. [GIBCO]), and 7-8 ml of delipidated LDL(27) was added per dish. Cells
were allowed to incubate for an additional 40-70 h in this environment before
being used for experimentation. Young cultures, in 2-ml sealed glass ampules at
cell densities of 5 x 105 cells/ml, were stored frozen ina dewar (MinnesotaValley
Engineering, NewPrague, Minn.) ofliquid nitrogen. Cells were first placed in a
solution of 10% glycerol, 20% FCS, in Ham's F-l2. Aliquots of 1 ml were sealed
in glass ampules, wrapped in cotton, and slowly frozen over dry ice overaperiod
of 3-5 h. Thevials were then stored in liquid nitrogen until use. Fresh cultures
were restarted by quickly thawing a vial in a 37°C water bath, transferring the
contents to a 50-mlplastic centrifugetube to which 20 mloffresh growthmedium
was added, and spinning the contents at 250 x gfor 10 min. The supernate was
removed and the pellet of cells was resuspended in 8 ml ofgrowth medium and
transferred to a Corning T-25 flask.
Cell Labeling 4'C
All solutionswere keptat0°-4°C. Cells werewashed three times in phosphate-
buffered saline (PBS) and once more in a buffer consisting of Medium 199(GIBCO) supplemented with 10 mM HEPES at pH 7.3 (buffer A) . Stock
solutions ofdil(3)-LDL were diluted to 6-12 jig/ml of LDL in bufferA . Cells on
glass cover slips were incubated with dil(3)-LDL at this concentration for 1-2h
at 4°C. They were then washed three times in PBS and incubated for 10 min in
Hank's balanced salt solution (HBSS ; GIBCO) supplemented with 2 mg/ml
albumin (Sigma), 2 mM calcium, and 10 mM Tris at pH 7.3 . Cells were then
washed onemore time in bufferA.
37'C Cell Labeling
Cells were treated as at 4°C, except for the following modifications . (a) Cells
were first labeled at 4°C, warmed to 37°C for the indicated period of time,
rapidly chilled by applying cold PBS, and then processed further at 4°C. (b)
Cells were washed at 4°C, labeled for the indicated period of time at 37°C,
rapidly chilled, and then processed further at 4°C.
Cell Fixation
Cells on glass cover slips were fixed in a4% solution of formaldehyde in PBS
for 10 min at 22°C, washed three times, andmounted for viewing in either buffer
A or PBS.
Antibody Labeling
Fluorescein-conjugated rabbit and anti-LDL (Ra-LDL) and fluorescein-con-
jugated goat anti-rabbit antibody (GAR) were obtained from N. L . Cappel
Laboratories, Cochranville, Pa . GAR antibody was preabsorbed on seven cover
slips of cells for 30 min per cover slip to remove antibodies with strong affinity
for cell surfaces that would otherwise lead to nonspecific labeling . Dil(3)-LDL-
or LDL-labeled cells were treated at 4°C for 40min with a 0.033 mg/ml solution
of Ra-LDL, washed three time in PBS, incubated for 40 min at 4°C with 0.2 mg/
ml GAR, washed three times in PBS, one time in HBSS containing 10mM Tris
and 2mg/ml albuminmonomer (Miles Laboratories, Inc., Elkhart, Indiana) for
10 min, and then fixed in formaldehyde .
HMG-CoA Reductase Assay
The assay was performed in the laboratory ofDrs . MichaelBrown and Joseph
Goldstein (University of Texas Health Science Center) . Cells were grown in
lipoprotein-deficient serum for 48 h and then incubated in minimum essential
medium plus 10% human lipoprotein-deficient serum plus penicillin and strep-
tomycin . The lipoproteins were added to a final concentration of 101Ag/ml and
the cells were incubated for 7 h . The cells were then harvested by scraping and
dissolved in the nonionic detergentKYRO-EOB (Proctor and Gamble, Cincin-
nati, Ohio) . HMG-CoA reductase activity was assayed as has been reported (27,
28).
Electron Microscopy
Samples of LDLand dil(3)-LDL were negatively stained in a2% solution of
sodium phosphotungstate, pH 7, and mounted and dried on carbon-coated grids.
Dil(3) Concentration in LDL
The concentrationofdil(3) in LDL was measured by placing aknown amount
of dil(3)-LDL (by protein) in 3 ml of ethanol and comparing the absorption at
552nm with a solution of 3.3 lag/ml ofdil(3) in ethanol . The ratio of dye to LDL
wascomputed by assuming a mass ratio of 1,000 (33) for dil(3) and 600,000 (22)
for the LDL protein .
Spectroscopy of Dil(3) in Solution
Equally concentrated samples of dil(3) in ethanol, octane, and water were
made by diluting a 0.5 mg/ml ethanol stock solution of dil(3) 150 times . The
concentration of dil(3) in a sample of dil(3)-LDL in water was calculated to
equal the diI(3) concentration of the other samples . Absorption spectra were
measured on a Cary dual beam spectrophotometer (Varian, Florham Park, N . J.)
and were corrected for the characteristic absorption ofthe sample cuvettes.
Photography
Cells were photographed on a Nikon Optiphot microscope with fluorescence
optics. Dil(3) fluorescence was excited at 520-550 nm and detected through a
580-nm barrier filter . Fluorescein fluorescence was excited at 450-480 nm and
photographed through a 515-am barrier filter to block the exciting light, and with
a 5,259 t 220 .4 interference filter (Ditric Optics, Inc., Hudson, Mass.) placed
directly in front of the camera .
RESULTS
Dil(3)-LDL antigenicity and binding specificity were checked
by indirect immunofluorescence (Fig . 1) . Cells were labeled at
4°C with dil(3)-LDL (Fig . 1 a) and then prepared for indirect
immunofluorescence with a fluorescein-labeled goat anti-rabbit
antibody against rabbit anti-LDL . The second antibody was
preabsorbed against seven cover slips of cells to prevent non-
specific antibody binding. Even though the fluorescein fluores-
cence that appears green can be distinguished from the orange-
red fluorescence of dil(3), an interference filter centered at
5,259 A with a 440A bandwidth and 73% peak transmission
was placed directly before the camera lens and above the
barrier filter during the photography of the fluorescein fluores-
cence. Dil(3) excited at 450-480 nm still fluoresces slightly
(orange), but the intensity is much less than that of the fluo-
rescein fluorescence intensity . The interference filter com-
pletely blocks all dil(3) fluorescence excited at either 450-480
or 520-550 nm . Unfortunately, it also reduced the fluorescence
intensity of the fluorescein fluorescence two- to threefold .
Comparison of the fluorescence from dil(3)-LDL excited at
520-550 rim. (Fig. 1 a) to that of the fluorescein-labeled anti-
body fluorescence excited at 450-480 nm (Fig . 1 b) shows an
identical distribution . This is easily seen by beginning at the
arrow which points to two fluorescent spots on Fig . 1 a and b
and following the fluorescence pattern along the length ofthe
cell. As a test of antibody specificity, cells in which either the
dil(3)-LDL or first antibody incubation was omitted produced
no staining when exposed to the fluorescein goat anti-rabbit
IgG (results not shown) . Cells labeled with native LDL and
then processed for indirect immunofluorescence had fluores-
cence distributions similar to that of dil(3)-LDL, except that
they were more intense. We attribute this slight loss ofintensity
to quenching of fluorescein fluorescence by dil(3) incorporated
in the LDL .
In Fig . 1 c are Ouchterlony immunodiffusion results which
confirm that dil(3)-LDL possess antigenicity similar to that of
LDL . Wells 1-5 contain rabbit anti-LDL (2 mg/ml), LDL (5
mg/ml), goat anti-rabbit IgG (2 mg/ml), goat anti-rabbit IgG
(2 mg/ml), and dil(3)-LDL (1 .2 mg/ml), respectively. Both
LDL and dil(3)-LDL form precipitan bands with rabbit anti-
LDL, but not with goat anti-rabbit IgG . Goat anti-rabbit
antibody in wells 3 and 4 precipitated in a heavy band with
rabbit antibody from well 1 . (The halo about wells 3 and 4 is
due to reflections from the dish .) When the precipitan band in
front of well 5 was examined under the fluorescence microscope
with 520-550-nm excitation, the characteristic orange-red flu-
orescence of dil(3) was observed to coincide with the precipi-
tate . These results indicate that dil(3)-LDL possesses antigen-
icity similar to that of LDL, and that the dil(3) fluorescence
originates from the locations where LDL is bound.
In Fig. 2 are micrographs of negatively stained native LDL
and dil(3)-LDL prepared by the three procedures described in
Materials and Methods. Fig. 2 a is a micrograph of negatively
stained LDL. The particles are similar in size and appearance
to LDL described in other reports (9, 24, 26). Fig . 2 b shows
dil(3)-LDL made by method 11. Its structure is similar to that
of native LDL in Fig. 2a, indicating retention of cholesterol
ester (26) . An occasional collapsed particle ofLDL can be seen
in Fig . 2b . To test whether the dil(3) would incorporate into
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(a) GM-3348 human fibroblasts labeled with 12 pg/ml of dil(3)-LDL at 4°C for 2 h and then processed at 4°C for
indirect immunofluorescence with fluorescein-conjugated antibody against anti-LDL antibody . This micrograph shows the
distribution of dil(3)-LDL in dil(3) fluorescence excited between 520 and 550 nm . (b) The same cell as in a but the fluorescence
distribution of particles is now due to fluorescein excitation between 450 and 480 nm . This micrograph was taken through an
interference filter centered at 5,259 A that eliminated all dil(3) fluorescence regardless of the excitation wavelength . By beginning
at the arrows, a one-to-one correspondence can be observed between the fluorescence distributions of a and b . (c) In this
Ouchterlony immunodiffusion plate, wells 1-5 contain, respectively, 2 mg/ml rabbit anti-LDL, 5 mg/ml LDL, 2 mg/ml GAR, 2 mg/
ml GAR, and 1 .2 mg/ml dil(3)-LDL . Both LDL and dil(3)-LDL precipitated with rabbit anti-LDL, but not with GAR . The precipitan
band in front of well 5 also had the characteristic fluorescence of dil(3) when excited at 520-550 nm . Bar, 8 .5Am .
the LDL-phospholipid matrix we added dil(3) in methanol to
a solution of LDL. The methanol injection was required due
to the insolubility of dil(3) in water (33) . The resulting diI(3)-
LDL is shown in Fig. 2c. As is evident, the normal LDL
structure has remained. This derivative bound to fibroblasts.
Fig. 2 d shows dil(3)-LDL made by method 1, in which the
LDL undergoes heptane extraction (shown at smaller magni-
fication than Fig. 2 a-c). All the particles are collapsed, indi-
cating that the cholesterol esters have been removed (26).
Spectroscopic measurements indicated that -45 molecules
of dil(3) were incorporated into each molecule of LDL . This
corresponds to 6-7% of the total phospholipid per LDL (24),
and would place one diI(3) molecule every 50 A in the LDL
shell surface if the molecules were homogeneously distributed.
In Fig . 3 are absorption spectra of equal concentrations of
dil(3) in water, ethanol, octane, and as dil(3)-LDL in water.
For ethanol solutions of dil(3), this concentration falls in the
linear range of an optical density (552 nm) vs . concentration
plot (results not shown) . The relative absorption peak heights
at 552 nm, A(552), reflect the changes in extinction coefficients
for dil(3) due to changes of solvent polarizability . The ratio of
peak intensities, A(552)/A(514), is inversely related to the
dimerization state (33) of the diI(3). We conclude from these
ratios that the dil(3) in LDL is mostly in monomer form . The
peak heights at 552 nm for dil(3) associated with the LDL
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show that it is not completely submerged in the hydrophobic
interior of the LDL, since the peak intensity at 552 nm is in
between the values for dil(3) in water and the reduced value at
552 in octane . These spectra are consistent with a placement of
dil(3) in LDL, like a phospholipid with the polar head group
exposed to water and the hydrophobic carbon chain in the
interior.
The inhibitory effects of diI(3)-LDL and normal LDL on
the activity of HMG-CoA reductase were compared. Method
lI diI(3)-LDL is almost as effective as unextracted LDL in
inhibiting this enzyme. It inhibited HMG-CoA reductase by
>80% inhuman fibroblasts when applied at a concentration of
10 leg/ml . Some of the activity difference can probably be
accounted for by a loss of cholesterol ester from LDL during
the dil(3) incorporation procedure, rather than any loss of
dil(3)-LDL binding affinity .
Fig . 4 presents fluorescence and phase-contrast micrographs
of normal and mutant human fibroblasts labeled with dil(3)-
LDL . There were no differences in cell staining by dil(3)-LDL .
There were no differences in cell staining by dil(3)-LDL made
by either method I or Il . Therefore the surface binding distri-
bution and internalization properties of dil(3)-LDL appear
indifferent to the loss ofcholesterol ester produced by method
I as expected for LDL (26) . Fig. 4a shows labeled cells from
normal GM-3348 human fibroblasts . Most of the fluorescent0
c
0
FIGURE 2 Electron micrographs of negatively stained samples of LDL (a), dil(3)-LDL prepared by method II (b), dil(3)-LDL
prepared by method III (larger particles against background) (c), and dil(3)-LDL prepared by method I (d) . The collapse of the
structure of LDL seen in (d) is due to removal of cholesterol ester from the LDL shell . a-c : bar, 368 R ; d : bar, 140 ,$ .
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FIGURE 3
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Spectra of equal concentrations of di1(3) in water, octane,
ethanol, and as dil(3)-LDL in water . These spectra are consistent
with a phospholipid-type orientation of dil(3) in the shell of LDL
(see text) .
dots are expected to correspond to three to five LDL receptors
located in coated areas of membrane (25) . The fluorescence
was extremely bright and has a distribution similar to that seen
on normal fibroblasts with 3-pyrenemethyl-23,24-dinor-5 cho-
len-22-oate-3 betayl oleate (PMCA oleate)-LDL or indirect
immunofluorescence labeling of bound LDL (25). Normal
GM-3348 fibroblasts treated in our laboratory with PMCA
oleate reconstituted LDL (a gift of Monty Kreiger) produced
a fluorescence distribution similar to that in Fig . 4a. The cells
illustrated in Fig . 4 c and d, and e and f, were treated with
diI(3)-LDL and photographed under identical conditions . The
cells in Fig . 4 c and d are GM-2408A mutant fibroblasts which
have a homogeneous distribution of surface LDL receptors.
According to Anderson et al . (7), these receptors are not
preferentially located in coated pits but are distributed as
individual or groups of two or three receptors (25) . Thus the
fluorescent dots are expected to correspond to from 1 to 3 LDL
molecules. The receptor-negative mutants, GM-2000, do not
bind LDL . This is clearly demonstrated in Fig . 4e, which was
exposed and printed under conditions identical to those in Fig .
4c .
Mutant GM-2408A and normal GM-3348 cells were labeled
with diI(3)-LDL at 4°C. Comparison of the fluorescence dis-
tribution between them (not shown) confirms observations (17,
25) that LDL on normal human fibroblasts often appears in
linear arrays, while LDL onGM-2408A in most cases seems to
be homogeneously dispersed. We have observed occasional
mutant GM-2408A cells which have receptors arrayed in a
linear pattern.
Fig . 5 a and b showGM-2408A cells that were photographed
and printed under identical conditions, but the labeling differed
in that the cell in Fig . 5bwas simultaneously exposed to a 100-
fold excess of unlabeled LDL during diI(3)-LDL labeling at
4°C . To determine that the displacement of DiI(3)-LDL in
Fig. 5b was not simply due to excess protein in the labeling
medium, cells were labeled with our standard conditions in the
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Alternate fluorescence and phase-contrast micrographs of dil (3)-LDL fluorescence on normal human fibroblasts (a and
b) ; GM-2408A LDL-receptor internalization-defective human fibroblasts (c and d) ; and GM-2000 LDL-receptor-negative human
fibroblasts (e and f) . Bar, 8 .5 jm .
presence of 2 mg/ml albumin . They showed fluorescence pat-
terns similar to those in Fig. 5 a .
Quantitative photocount measurements of the absolute in-
tergrated fluorescent intensity were made on GM-2408A cells
treated as in Fig . 5 a and b . Results are presented in Table I .
After correction for cellular autofluorescence, which includes
unlabeled native LDL fluorescence, the total nonspecific fluo-
rescence intensity of dil(3)-LDL treated cells is only 0.5-3% of
the total fluorescence . Thus, within the uncertainty of the
measurement, an 80-fold excess of native LDL completely
prevents dil(3)-LDL binding .
To insure that the dil(3)-LDL-labeling patterns were not
somehow changed by receptor redistribution during 4°C in-
cubations, cells were first fixed with formaldehyde and then
labeled. Both GM-2408A and GM-3348 displayed LDL fluo-
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rescence patterns identical to those already shown for live cells .
Cells labeled at 4°C, kept at 4°C, and then examined on a 4°C
temperature-controlled microscope stage also produced label-
ing patterns identical to those seen in Figs . 1-3 .
Fig . 6 shows cells that were exposed to temperatures of 37°C
during or after labeling with dil(3)-LDL . Each respective pair
(a-b, c-d, e-f) was photographed and printed under identical
conditions . Fig . 6 a shows GM-2408A cells that were labeled
for 15 min with diI(3)-LDL, whereas the cell in Fig . 6 b was
simultaneously treated with a 100-fold excess of unlabeled
LDL in addition to diI(3)-LDL . The slight fluorescence seen
in Fig . 6 6 is probably due to diI(3)-LDL internalized nonspe-
cifically . The fluorescence is visible as a result of the extreme
brightness of single dil(3)-LDL particles. The pair in 6 c and d
represents GM-2408A cells that were labeled for 15 min atFIGURE 5
￿
(a) GM-2408A human fibroblasts labeled at 4°C for2 h with 12 Ag/ml of dil(3)-LDL . (b) GM-2408A labeled as in a with
12 Wg/ml of dil(3)-LDL plus a 100-fold excess of unlabeled LDL . These micrographs were exposed and printed under identical
conditions. The arrows in b indicate the border of the cell . LDL completely prevented the binding of dil(3)-LDL in b, whereas
dil(3)-LDL binding was not prevented by 2 mg/ml albumin . The surface of the center of the cell in a is not quite in focus due to
the limited depth of field of the objective lens . This results in adefocused fluorescence image from this area in contrast to the cell
periphery . Bar, 8.5 pm .
TABLE I estimate that the fluorescent clusters contain in general <I0%
Specificity of Dil(3)-LDL Binding to Fibroblasts
￿
of the homogeneously bound dil(3)-LDL remaining with the
cell. In contrast the normal cells internalize all peripherally
bound dil(3)-LDL .
Cells were washed and labeled at 4°C with the indicated amounts of LDLand
dil(3)-LDL as described in Materials and Methods . All photocount results are
the average of 10 measurements with each measurement performed on a
different cell . Intensities were measured by illuminating an area which re-
mained constant on all samples with the 514-nm line of an argon-ion laser
directed through a x 100 phase-objective of a Zeiss Universal microscope .
Fluorescence intensity was monitored through a Schott OG530 barrier filter
by an RCA C31-034 photomultiplier (34) .
37°C with and without 5mg/ml ofheparin sulfate . The heparin
completely displaced the LDL from its receptor . Heparin also
displaced and prevented the binding of LDL at 4°C when
incubated simultaneously with or subsequent to dil(3)-LDL
incubation (results not shown) . The pair Fig. 6 e andf show
GM-3348 and GM-2000 cells that were first labeled with dil(3)-
LDL at 4°C, washed, and then incubated at 37°C for 15 min .
The normal GM-3348 fibroblasts in Fig . 6e rapidly internalized
the dil(3)-LDL . The fluorescence probably originates from
lysosomes (7) that are becoming distributed about the nucleus .
The GM-2000 cells of Fig. 6f are not fluorescent due to the
lack ofLDL binding at 4°C.
The fluorescence distribution of dil(3)-LDL on Fig . 6e is
much more heterogeneous than that of either Fig . 6 a or c.
Labeling has disappeared from peripheral areas of the cell in
Fig . 6 e, whereas in the GM-2408A mutants the peripheral and
general surface labelings are homogeneous enough to delineate
the cell. It is evident from the micrographs that the sizes ofthe
fluorescent clusters in Fig . 6a and c are smaller than those of
Fig . 6 e. The difference between mutants and normals is also
true of GM-2408A first labeled at 4°C and then incubated at
37°C for 15-20 min . Exposure to 37°C for 15-20 min is enough
to produce some fluorescent clusters in the GM-2408A mutants
that appear to be internalized as seen by exclusion from the
nucleus in some cases and focus below the cell membrane . We
DISCUSSION
The diI(3)-LDL developed and used here has the antigenic,
enzyme inhibition, binding, and internalization properties ex-
pected of normal LDL. Antibody labeling of dil(3)-LDL in-
dicates that it contains antigenicity similar to that of normal
LDL . The indirect immunofluorescence experiment shows di-
rectly that the dil(3) remains associated with theLDL once the
complex binds. This association is also indicated by Ouchter-
lony immunodiffusion and the large concentration of dil(3) in
solution with LDL (87 pg/ml), since dil(3) is water insoluble
(32) .
Three methods are described to incorporate dil(3) into LDL .
Method 11 evolved from method I and was developed for the
following reasons. We believed that because the chromophore
of dil(3) is charged (Fig. 7) it is probably not soluble in the
nonpolar interior of LDL . In addition, Kreiger et al. have
shown that esters oflong-chain saturated fatty acids cannot be
incorporated into the core ofLDL. Therefore, it is not necessary
to remove the cholesterol esters from the LDL, because they
are not being replaced by the dil(3), and this lack of incorpo-
ration and failure to replace the cholesterol ester probably
accounts for the collapsed appearance ofLDL in Fig. 2 d. We
believed that the yield ofdil(3)-LDL from starch in method I
could be improved by salting in the dil(3)-LDL . High salt
extractions (26) had previously been used to remove starch-
boundLDL with 60% recovery . By extracting dil(3)-LDL with
0.12 N NaCl from starch, our yield of LDL protein increased
six- to eightfold . The observation that dil(3) would incorporate
into both native and extractedLDL (Fig . 2 b and d) along with
our belief that it was too charged to partition into the choles-
terol ester fraction of LDL motivated method III . If dil(3)
could directly incorporate into LDL from aqueous solution, it
must first partition into the phospholipid layer . The results
including incorporation by method III, comparison of the
absorption spectra of dil(3)-LDL with dil(3) in solutions of
differing polariability, its known charge, and its saturated fatty-
acid carbon chains indicate dil(3) partitions into the LDL
phospholipid shell .
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Samples
dil(3)-
LDL
Wglmi
LDL
mgImi
Photocounts
GM-2408A 12 - 90,800 t 33,400
GM-2408A 12 1 7,640 t 1,657
GM-2408A - 1 7,200 t 2,570
GM-2408A - - 5,350 t 1,790FIGURE 6
￿
Each pair of micrographs (a and b), (c and d), and (e and f) was exposed and printed under identical conditions . (a)
GM-2408A fibroblasts labeled with 12lAg/ml of dil(3)-LDL for 15 min at 37°C . (b) Cell treated as in a with 12 pg/ml of dil(3)-LDL
plus a 100-fold excess of unlabeled LDL . (c) GM-240ßA treated as in a . (d) GM-240ßA treated as in c with 12 Wg/ml dil(3)-LDL plus
5 mg/ml heparin sulfate . (e) Normal GM-3348 fibroblast labeled with 12 micrograms/ml dil(3)-LDL for 2 h at 4°C, incubated at
37°C for 15 min, and fixed in formaldehyde. ( f) LDL receptor-negative GM-2000 fibroblast treated as in e . Bar, 8 .5 lim .
We have shown that the fluorescence distribution of dil(3)-
LDL on the three cell lines GM-3348, GM-240ßA, and GM-
2000 agree with results obtained by Anderson et al. using other
fluorescence techniques (17, 25) . The most sensitive assay
involves incubation of the LDL receptor-negative GM-2000
line . At 4°C, this cell line exhibits no dil(3) fluorescence after
incubation with dil(3)-LDL, indicating that negligible nonspe-
cific fluorescence occurs upon labeling. This contrasts with the
intense punctate labeling of the normal GM-3348 fibroblasts
and the mutant GM-240ßA fibroblasts . Comparison of dil(3)
fluorescence between these two lines reveals a qualitative dif-
ference in fluorescence at 4°C and a gross difference at 37°C .
The GM-240ßA mutants retain some capability for internaliz-
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ing diI(3)-LDL at 37°C . In contrast to the normal cells, the
percentage internalized appears to be much less, and the dis-
tribution in the cell is slightly different . We do not know
whether this involves another endocytotic pathway without
coated vesicles, whether the LDL receptor in this instance
happens to be located in a coated area by chance . This second-
ary process is only evident due to the extreme brightness of a
few molecules of dil(3)-LDL . The diI(3)-LDL-labeling results
at 4°C also confirm results (17, 25) that LDL receptors are
prepatched on the membrane of normal cells and in most
instances homogeneously distributed on the mutant line GM-
2408A . GM-240ßA cells occasionally do occur which have
linear arrays of receptors. The vast majority ofLDL receptorsChemical Structure of diI(3)C 18
CH 3 CH3
FIGURE 7
￿
Structure of the lipid analogue dil(3)-LDL .
in this cell line are not associated with coated areas of mem-
brane (25). It is not known whether the alignment in either
case is due to a specific interaction with a cellular component.
Two other experiments confirmed the binding specificity of
dil(3)-LDL. DiI(3)-LDL was prevented from binding by an
excess of unlabeled LDL, and heparin sulfate (30) displaced or
prevented dil(3)-LDL binding to the LDL receptor.
We have incorporated diI(3) into LDL for the purpose of
studying receptor-ligand interactions and diffusion. The -45
fluorophores incorporated per molecule allow receptor ligand
complexes as small as 1-3 in number to be observed. The
carbocyanine fluorophore is fairly photostable (33), and so
multiple time-lapse observations can be made on the receptor
complexes. Furthermore, the high concentration offluorophore
produces a large contrast between labeled and unlabeled areas
of the cell surface. This permits experiments to be carried out
in the presence oflow receptor density.
When the receptor number is low, as for LDL, insulin, and
other hormone systems (1, 2, 36, 37), the fluorophore number
is especially critical. The number of fluorophores bound per
unit area on the cell surface is a function of both receptor
density and the stoichiometry between the ligand and conju-
gated dye. Rhodamine and fluorescein derivatives are the most
common fluorescent conjugates. When attached to either LDL
or the hormones mentioned above in equimolar ratios, fluo-
rophore intensity is too low to permit fluorescence visualization
ofligands in many geometries and cell types. This problem has
been circumvented in one system by employing a cell line with
abnormally high numbers of receptors (2). Other attempts to
circumvent this numbers problem have relied on attaching
more fluorescein or rhodamine dye groups to the ligand either
directly or indirectly (35, 36, 37).
We believe that by incorporating a lipid-soluble dye or a
cholesterol ester substitute into LDL, the arginine-and lysine-
associated (38) binding sites of LDL that is not being exposed
to amino reactive dyes remain intact. The ratio of intensity
between cells labeled with diI(3)-LDL and cells treated with
diI(3)-LDL plus an 80-fold excess of LDL is between 50 and
200. This confirms that there is negligible nonspecific binding
(39, 40) between the dye and cell-surface proteins other than
LDL. Thus, it should be possible to covalently modify selected
compoents of LDL, incorporate the dil(3), and determine the
effects of the modification by observing changes in the fluores-
cence patterns compared to those of unmodified diI(3)-LDL.
Experiments of this type appear possible because we have been
able to observe individual LDL receptor complexes and or
small clusters of 1-3 receptor complexes. This capability en-
ables us to localize individual LDL-receptor complexes, and,
in addition, to determine the statistical diffusion properties of
the complex.
We have used the diI(3)-LDL to study receptor-ligand dif-
fusion and internalization of GM-3348 and GM-2408A cells.
Preliminary results indicate that the LDL-receptor complex is
immobilized and that when freed from this linkage the LDL-
receptor complex undergoes Brownian motion consistent with
the Saffman-Delbruck (41, 42) diffusion theory for a free
particle in two dimensions. This work is to be reported in a
subsequent paper.
The complexity of the LDL molecule allows it to be labeled
in a number of ways. The protein, cholesterol ester, and
phospholipid portions can be labeled with 3 different probes to
study both the internal environment of LDL and the path it
follows afterbinding to its surface receptor. These fluorescence
labeling techniques can also be applied to the other serum
lipoproteins because they also contain lipid, cholesterol, and
protein components.
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